Please use this identifier to cite or link to this item: http://hdl.handle.net/2381/16846
Title: A genome-wide association study reveals variants in ARL15 that influence adiponectin levels.
Authors: Richards, J. B.
Waterworth, D.
O'Rahilly, S.
Hivert, M. F.
Loos, R. J.
Perry, J. R.
Tanaka, T.
Timpson, N. J.
Semple, R. K.
Soranzo, N.
Song, K.
Rocha, N.
Grundberg, E.
Dupuis, J.
Florez, J. C.
Langenberg, C.
Prokopenko, I.
Saxena, R.
Sladek, R.
Aulchenko, Y.
Evans, D.
Waeber, G.
Erdmann, J.
Burnett, M. S.
Sattar, N.
Devaney, J.
Willenborg, C.
Hingorani, A.
Witteman, J. C.
Vollenweider, P.
Glaser, B.
Hengstenberg, C.
Ferrucci, L.
Melzer, D.
Stark, K.
Deanfield, J.
Winogradow, J.
Grassl, M.
Hall, A. S.
Egan, J. M.
Thompson, John R.
Ricketts, S. L.
König, I. R.
Reinhard, W.
Grundy, S.
Wichmann, H. E.
Barter, P.
Mahley, R.
Kesaniemi, Y. A.
Rader, D. J.
Reilly, M. P.
Epstein, S. E.
Stewart, A. F.
Van Duijn C. M.
Schunkert, H.
Burling, K.
Deloukas, P.
Pastinen, T.
Samani, Nilesh J.
McPherson, R.
Davey Smith G.
Frayling, T. M.
Wareham, N. J.
Meigs, J. B.
Mooser, V.
Spector, T. D.
GIANT, Consortium
First Published: 11-Dec-2009
Publisher: Public Library of Science
Citation: PLoS Genetics, 2009, 5 (12), pp. e1000768-e1000768
Abstract: The adipocyte-derived protein adiponectin is highly heritable and inversely associated with risk of type 2 diabetes mellitus (T2D) and coronary heart disease (CHD). We meta-analyzed 3 genome-wide association studies for circulating adiponectin levels (n = 8,531) and sought validation of the lead single nucleotide polymorphisms (SNPs) in 5 additional cohorts (n = 6,202). Five SNPs were genome-wide significant in their relationship with adiponectin (P< or =5x10(-8)). We then tested whether these 5 SNPs were associated with risk of T2D and CHD using a Bonferroni-corrected threshold of P< or =0.011 to declare statistical significance for these disease associations. SNPs at the adiponectin-encoding ADIPOQ locus demonstrated the strongest associations with adiponectin levels (P-combined = 9.2x10(-19) for lead SNP, rs266717, n = 14,733). A novel variant in the ARL15 (ADP-ribosylation factor-like 15) gene was associated with lower circulating levels of adiponectin (rs4311394-G, P-combined = 2.9x10(-8), n = 14,733). This same risk allele at ARL15 was also associated with a higher risk of CHD (odds ratio [OR] = 1.12, P = 8.5x10(-6), n = 22,421) more nominally, an increased risk of T2D (OR = 1.11, P = 3.2x10(-3), n = 10,128), and several metabolic traits. Expression studies in humans indicated that ARL15 is well-expressed in skeletal muscle. These findings identify a novel protein, ARL15, which influences circulating adiponectin levels and may impact upon CHD risk.
The adipocyte-derived protein adiponectin is highly heritable and inversely associated with risk of type 2 diabetes mellitus (T2D) and coronary heart disease (CHD). We meta-analyzed 3 genome-wide association studies for circulating adiponectin levels (n = 8,531) and sought validation of the lead single nucleotide polymorphisms (SNPs) in 5 additional cohorts (n = 6,202). Five SNPs were genome-wide significant in their relationship with adiponectin (P≤5×10−8). We then tested whether these 5 SNPs were associated with risk of T2D and CHD using a Bonferroni-corrected threshold of P≤0.011 to declare statistical significance for these disease associations. SNPs at the adiponectin-encoding ADIPOQ locus demonstrated the strongest associations with adiponectin levels (P-combined = 9.2×10−19 for lead SNP, rs266717, n = 14,733). A novel variant in the ARL15 (ADP-ribosylation factor-like 15) gene was associated with lower circulating levels of adiponectin (rs4311394-G, P-combined = 2.9×10−8, n = 14,733). This same risk allele at ARL15 was also associated with a higher risk of CHD (odds ratio [OR] = 1.12, P = 8.5×10−6, n = 22,421) more nominally, an increased risk of T2D (OR = 1.11, P = 3.2×10−3, n = 10,128), and several metabolic traits. Expression studies in humans indicated that ARL15 is well-expressed in skeletal muscle. These findings identify a novel protein, ARL15, which influences circulating adiponectin levels and may impact upon CHD risk.
DOI Link: 10.1371/journal.pgen.1000768
ISSN: 1553-7390
eISSN: 1553-7404
Links: http://hdl.handle.net/2381/16846
http://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1000768
Type: Journal Article
Rights: Copyright: © 2009 Richards et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Appears in Collections:Published Articles, Dept. of Health Sciences

Files in This Item:
File Description SizeFormat 
journal.pgen.1000768.pdf665.02 kBAdobe PDFView/Open


Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.